These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 23153673
21. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes. Tanaka K, Tani Y, Asai J, Nemoto F, Kusano Y, Suzuki H, Hayashi Y, Asahi K, Nakayama M, Miyata T, Watanabe T. Diabet Med; 2012 Apr; 29(4):492-500. PubMed ID: 21916970 [Abstract] [Full Text] [Related]
22. Hand, shoulder and back stiffness in long-term type 1 diabetes; cross-sectional association with skin collagen advanced glycation end-products. The Dialong study. Holte KB, Juel NG, Brox JI, Hanssen KF, Fosmark DS, Sell DR, Monnier VM, Berg TJ. J Diabetes Complications; 2017 Sep; 31(9):1408-1414. PubMed ID: 28705609 [Abstract] [Full Text] [Related]
23. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes. Miura J, Yamagishi Si, Uchigata Y, Takeuchi M, Yamamoto H, Makita Z, Iwamoto Y. J Diabetes Complications; 2003 Sep; 17(1):16-21. PubMed ID: 12505751 [Abstract] [Full Text] [Related]
25. Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. White NH, Sun W, Cleary PA, Tamborlane WV, Danis RP, Hainsworth DP, Davis MD, DCCT-EDIC Research Group. Diabetes; 2010 May; 59(5):1244-53. PubMed ID: 20150283 [Abstract] [Full Text] [Related]
29. Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction. Januszewski AS, Sachithanandan N, Karschimkus C, O'Neal DN, Yeung CK, Alkatib N, Jenkins AJ. Diabet Med; 2012 Jun; 29(6):726-33. PubMed ID: 22211881 [Abstract] [Full Text] [Related]
31. Influence of remission and its duration on development of early microvascular complications in young adults with type 1 diabetes. Niedzwiecki P, Pilacinski S, Uruska A, Adamska A, Naskret D, Zozulinska-Ziolkiewicz D. J Diabetes Complications; 2015 Jun; 29(8):1105-11. PubMed ID: 26427560 [Abstract] [Full Text] [Related]
33. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910 [Abstract] [Full Text] [Related]
36. Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus. Lyons TJ, Bailie KE, Dyer DG, Dunn JA, Baynes JW. J Clin Invest; 1991 Jun; 87(6):1910-5. PubMed ID: 1904067 [Abstract] [Full Text] [Related]
37. The hemoglobin glycation index is not an independent predictor of the risk of microvascular complications in the Diabetes Control and Complications Trial. Lachin JM, Genuth S, Nathan DM, Rutledge BN. Diabetes; 2007 Jul; 56(7):1913-21. PubMed ID: 17360979 [Abstract] [Full Text] [Related]
40. Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Beisswenger PJ, Makita Z, Curphey TJ, Moore LL, Jean S, Brinck-Johnsen T, Bucala R, Vlassara H. Diabetes; 1995 Jul; 44(7):824-9. PubMed ID: 7789650 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]